1. Breaking the rules: decision-making under absolute resource constraints

   • Peter Lindgren

   Editorial 06 September 2022 Pages: 1259 - 1261

2. COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach

   • Matthias Klumpp
   • Dominic Loske
   • Silvio Bicciato

   Original Paper Open access 11 January 2022 Pages: 1263 - 1285

   

3. Value drivers of development stage biopharma companies

   • Daniel Tobias Michaeli
   • Hasan Basri Yagmur
   • Thomas Michaeli

   Original Paper Open access 17 January 2022 Pages: 1287 - 1296

   

4. Do we care about high-cost patients? Estimating the savings on health spending by integrated care

   • Karen Geurts
   • Marc Bruijnzeels
   • Erik Schokkaert

   Original Paper 25 January 2022 Pages: 1297 - 1308

   

5. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

   • Don Husereau
   • Michael Drummond
   • CHEERS 2022 ISPOR Good Research Practices Task Force

   Original Paper Open access 27 January 2022 Pages: 1309 - 1317

   

6. Does the abolition of copayment increase ambulatory care utilization?: a quasi-experimental study in Germany

   • Mingming Xu
   • Benjamin Bittschi

   Original Paper 27 January 2022 Pages: 1319 - 1328

7. The impact of ambulatory care spending, continuity and processes of care on ambulatory care sensitive hospitalizations

   • Wiebke Schuettig
   • Leonie Sundmacher

   Original Paper Open access 29 January 2022 Pages: 1329 - 1340

   

8. Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above

   • Zsombor Zrubka
   • Péter Vékás
   • Márta Péntek

   Original Paper Open access 31 January 2022 Pages: 1341 - 1355

   

9. Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data

   • Aileen R. Neilson
   • Gareth T. Jones
   • Paul McNamee

   Original Paper Open access 03 February 2022 Pages: 1357 - 1369

   

10. Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective

    • Daniela Zinzi
    • Ioanna Vlachaki
    • Dilip Nathwani

    Original Paper Open access 03 February 2022 Pages: 1371 - 1381

    

11. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis

    • Jiaer Lin
    • Carlos King Ho Wong
    • Nan Luo

    Original Paper 04 February 2022 Pages: 1383 - 1395

    

12. Does voluntary health insurance improve health and longevity? Evidence from European OECD countries

    • Simona Laura Dragos
    • Codruta Mare
    • Alexandra-Anca Purcel

    Original Paper 06 February 2022 Pages: 1397 - 1411

    

13. Correction: Lifetime direct healthcare costs of treating colorectal cancer: a systematic review

    • Nazim Bhimani
    • Geoffrey Y. M. Wong
    • Thomas J. Hugh

    Correction 22 September 2022 Pages: 1413 - 1413